Postexposure treatment of marburg virus infection

Thomas Geisbert, Lisa E. Hensley, Joan B. Geisbert, Anders Leung, Joshua C. Johnson, Allen Grolla, Heinz Feldmann

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was administered 48 h postinfection.

Original languageEnglish (US)
Pages (from-to)1119-1122
Number of pages4
JournalEmerging Infectious Diseases
Volume16
Issue number7
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Marburgvirus
Virus Diseases
Vaccines
Monkey Diseases
Vesicular Stomatitis
Macaca mulatta
Haplorhini
Viruses
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology
  • Medicine(all)

Cite this

Geisbert, T., Hensley, L. E., Geisbert, J. B., Leung, A., Johnson, J. C., Grolla, A., & Feldmann, H. (2010). Postexposure treatment of marburg virus infection. Emerging Infectious Diseases, 16(7), 1119-1122. https://doi.org/10.3201/eid1607.100159

Postexposure treatment of marburg virus infection. / Geisbert, Thomas; Hensley, Lisa E.; Geisbert, Joan B.; Leung, Anders; Johnson, Joshua C.; Grolla, Allen; Feldmann, Heinz.

In: Emerging Infectious Diseases, Vol. 16, No. 7, 07.2010, p. 1119-1122.

Research output: Contribution to journalArticle

Geisbert, T, Hensley, LE, Geisbert, JB, Leung, A, Johnson, JC, Grolla, A & Feldmann, H 2010, 'Postexposure treatment of marburg virus infection', Emerging Infectious Diseases, vol. 16, no. 7, pp. 1119-1122. https://doi.org/10.3201/eid1607.100159
Geisbert T, Hensley LE, Geisbert JB, Leung A, Johnson JC, Grolla A et al. Postexposure treatment of marburg virus infection. Emerging Infectious Diseases. 2010 Jul;16(7):1119-1122. https://doi.org/10.3201/eid1607.100159
Geisbert, Thomas ; Hensley, Lisa E. ; Geisbert, Joan B. ; Leung, Anders ; Johnson, Joshua C. ; Grolla, Allen ; Feldmann, Heinz. / Postexposure treatment of marburg virus infection. In: Emerging Infectious Diseases. 2010 ; Vol. 16, No. 7. pp. 1119-1122.
@article{9211385962ca4e869e8870e03e8a02ab,
title = "Postexposure treatment of marburg virus infection",
abstract = "Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was administered 48 h postinfection.",
author = "Thomas Geisbert and Hensley, {Lisa E.} and Geisbert, {Joan B.} and Anders Leung and Johnson, {Joshua C.} and Allen Grolla and Heinz Feldmann",
year = "2010",
month = "7",
doi = "10.3201/eid1607.100159",
language = "English (US)",
volume = "16",
pages = "1119--1122",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "7",

}

TY - JOUR

T1 - Postexposure treatment of marburg virus infection

AU - Geisbert, Thomas

AU - Hensley, Lisa E.

AU - Geisbert, Joan B.

AU - Leung, Anders

AU - Johnson, Joshua C.

AU - Grolla, Allen

AU - Feldmann, Heinz

PY - 2010/7

Y1 - 2010/7

N2 - Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was administered 48 h postinfection.

AB - Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was administered 48 h postinfection.

UR - http://www.scopus.com/inward/record.url?scp=77954451839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954451839&partnerID=8YFLogxK

U2 - 10.3201/eid1607.100159

DO - 10.3201/eid1607.100159

M3 - Article

VL - 16

SP - 1119

EP - 1122

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 7

ER -